Journal of Colloid and Interface Science, Journal Year: 2024, Volume and Issue: 681, P. 319 - 330
Published: Nov. 23, 2024
Language: Английский
Journal of Colloid and Interface Science, Journal Year: 2024, Volume and Issue: 681, P. 319 - 330
Published: Nov. 23, 2024
Language: Английский
Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 161355 - 161355
Published: March 1, 2025
Language: Английский
Citations
0Journal of Colloid and Interface Science, Journal Year: 2025, Volume and Issue: 690, P. 137332 - 137332
Published: March 14, 2025
Language: Английский
Citations
0Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 500, P. 157232 - 157232
Published: Oct. 30, 2024
Language: Английский
Citations
2Advanced Functional Materials, Journal Year: 2024, Volume and Issue: 34(46)
Published: July 1, 2024
Abstract The heterogeneity and immunosuppression microenvironment of ovarian cancer seriously restrict the efficiency monomodal treatment. Emerging multimodal therapy strategies based on sonodynamic with enhanced antitumor effects have attracted intensive attention in quest to combat cancer. However, exploring highly efficient sonosensitizers integrating chemodynamic/sonodynamic/immunotherapies reversing immunosuppressive tumor (TME) capacity is urgently desired but remains challenging. Here, a facile strategy designed synthesize immunomodulating sonocatalytic nanoagents (IrT‐SCN) dual‐functional Ir‐N centers narrow bandgap for potentiating immunotherapy. IrT‐SCN 2 4 conjugated networks show reduced bandgap, moderate interaction H O , production reactive oxygen species (ROS). Such ROS capabilities include: 1) utilizing TME catalytically generate potent as well abundant superoxide anion (•O − ) singlet ( 1 radicals; 2) external ultrasound (US) irradiation can also boost simultaneously; 3) M1 polarization tumor‐associated macrophages immune effect promote outcome This finding provides proof‐of‐concept evidence future development oncological treatments other ROS‐related biomedical fields.
Language: Английский
Citations
1Journal of Inorganic Biochemistry, Journal Year: 2024, Volume and Issue: 260, P. 112695 - 112695
Published: Aug. 11, 2024
Language: Английский
Citations
1Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 15, 2024
Abstract The assembly of low‐immunogenic poly(ethylene glycol) nanoparticles (PEG NPs) for targeted delivery therapeutics (i.e., mitoxantrone and imidazoquinoline) improved photothermal‐immunotherapy is reported. PEG NPs incorporating targeting molecules hyaluronic acid are engineered via the templating metal–organic frameworks, which can circumvent accelerated blood clearance exhibit prolonged circulation time as well accumulation at tumor sites. under laser radiation induces immunogenic cell death cells, combined with toll‐like receptor 7/8 agonists imidazoquinoline to trigger immune responses cytotoxic T lymphocytes eradication cells. Furthermore, treatment induce tumor‐specific that inhibit metastatic lung growth. This reported provide a rational design cancer immunotherapy.
Language: Английский
Citations
1Advanced Materials, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 15, 2024
Cancer immunotherapy holds significant promise for improving cancer treatment efficacy; however, the low response rate remains a considerable challenge. To overcome this limitation, advanced catalytic materials offer potential in augmenting by modulating immunosuppressive tumor microenvironment (TME) through precise biochemical reactions. Achieving optimal targeting precision and therapeutic efficacy necessitates thorough understanding of properties underlying mechanisms tumor-targeted materials. This review provides comprehensive systematic overview recent advancements their critical role enhancing immunotherapy. It highlights types reactions, construction strategies materials, fundamental targeting, including passive, bioactive, stimuli-responsive, biomimetic approaches. Furthermore, outlines various tumor-specific strategies, encompassing tissue, cell, exogenous TME-responsive, cellular TME strategies. Finally, discussion addresses challenges future perspectives transitioning into clinical applications, offering insights that pave way next-generation therapies provide substantial benefits to patients settings.
Language: Английский
Citations
1Ultrasonics Sonochemistry, Journal Year: 2024, Volume and Issue: 111, P. 107105 - 107105
Published: Oct. 15, 2024
Language: Английский
Citations
0Journal of Colloid and Interface Science, Journal Year: 2024, Volume and Issue: 681, P. 319 - 330
Published: Nov. 23, 2024
Language: Английский
Citations
0